{
    "case_number": "CAC-UDRP-101040",
    "time_of_filling": "2015-08-18 11:31:22",
    "domain_names": [
        "PROAIRDISCOUNTCARD.COM"
    ],
    "case_administrator": "Lada Válková (Case admin)",
    "complainant": [
        "TEVA RESPIRATORY, LLC"
    ],
    "complainant_representative": "Matkowsky Law PC",
    "respondent": [
        "Health Matrix Direct, Inc."
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nComplainant is the U.S.-based respiratory division of Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. \r\n\r\nComplainant's ProAir® HFA Inhalation Aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. ProAir® HFA Inhalation Aerosol is the #1 dispensed quick-relief inhaler in the United States based on the number of prescriptions of ProAir HFA (IMS National Rx Audit, September 2014). The ProAir® trademark is clearly well-known in the albuterol category in the United States. ProAir® HFA revenues amounted to $ 1,448 million in 2014 (IMS National Sales Perspectives, for the year ending December 2014). Complainant's ProAir® RespiClick (albuterol sulfate) Inhalation Powder is indicated in patients 12 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. It is the first and only FDA-approved multidose breath-activated rescue inhaler. More information on ProAir® is available in the United States via <ProAir.com> or <MyProAir.com>. \r\n\r\nComplainant claims the disputed domain name is confusingly similar to Complainant's ProAir® registered trademark, in which Complainant has rights. \r\n\r\nRights and Legitimate Interest (Rules, 3(b)(ix)(2))\r\n\r\nComplainant contends it has its own savings card and assistance program for those that meet the eligibility requirements and understand and agree to the terms and conditions associated therewith. Respondent Health Matrix Direct, Inc. has a website at healthmatrixdirect.com, and according to the company overview at Bloomberg Business, offers its own prescription discount and assistance programs. Respondent’s offerings are not sponsored by, affiliated with, endorsed by, or otherwise connected in any way with Complainant’s savings card for Proair, or its assistance program.  Respondent has never been authorized, contracted, licensed or otherwise permitted by Complainant to use the Complainant's ProAir® trademark, nor is Respondent an authorized vender, supplier, or distributor of Complainant’s ProAir®, and there is no relationship between itself and the Respondent. Respondent is also not commonly known by the trademark, as is evidenced by the Whois record. \r\n\r\nThe disputed domain name is hosted on NS1.Bluehost.com and NS2.Bluehost.com. As part of the Bluehost User Agreement, Bluehost provides Parked Page Services on domains hosted with Bluehost. This services is provided through Google’s DomainPark program hosted by DoubleClick. This services presumably benefits the registrant through reduced hosting fees. Under the Bluehost.com user agreement, a user can opt out of the Parked Page Services at any time by simply replacing the default web page on the parked domain or pointing the DNS away from Bluehost.\r\n\r\nRespondent failed to opt out of the Parked Page Service.  As a result, ads for highly related products, including competitive products to Proair as well as unrelated commercial ads appear on the site aside the trademark PROAIRDISCOUNTCARD.COM, which incorporates the registered mark in its entirety and is substantially indistinguishable considering the other terms is a generic phrase related to Complainant's business.  According to Complainant this type of website, which is merely an advertising portal and parking page that offers click-through opportunities to websites operated by Complainant’s competitors generally does not constitute a bona fide offering of goods or services under the Policy.\r\n\r\nFinally, Complainant concludes that none of the foregoing establishes rights or a legitimate interest in the disputed domain name, but rather constitutes unfair use, resulting in misleading diversion. \r\n\r\nRegistration and Use in Bad Faith (Rules, 3(b)(ix)(2)) \r\n\r\nComplainant claims that the disputed domain name has attracted viewers for commercial gain, by confusions within the meaning of paragraph 4(b)(iv) of the Policy because it generates revenue from click-through referrals. \r\n\r\nThe disputed domain name was registered on 29 March 2012.",
    "other_legal_proceedings": "None",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name is identical or confusingly similar to a trademark or service mark in which the complainant has rights (within the meaning of paragraph 4(a)(i)of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Domain Name (within the meaning of paragraph 4(a)(ii)of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii)of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Mr. Etienne Wéry"
    ],
    "date_of_panel_decision": "2015-09-23 00:00:00",
    "informal_english_translation": "Trademark\r\n\r\nComplainant provides evidence it owns U.S. Reg. No. 3,166,297, for the mark ProAir, registered on 31 October 2006, in Class 5, covering inhalers filled with pharmaceutical preparations for the treatment of respiratory disease.",
    "decision_domains": {
        "PROAIRDISCOUNTCARD.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}